ADVENTRX Pharmaceuticals Inc ANX Financial and Strategic SWOT Analysis Review

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

  • $ 645
  • Industry report
  • by Firstword Pharma
  • Oct 2014

The potential blockbuster status of Novartis' LCZ696 has seemingly been cemented in the eyes of the Street thanks to solid results from the Phase III PARADIGM-HF study that were presented over the weekend. Indeed, the chronic heart failure agent is believed to represent both a significant growth drive ...

Industries: Pathology | Countries: United States

Protalix Biotherapeutics Inc

Protalix Biotherapeutics Inc

  • $ 55
  • Company report
  • by Wright Investors' Service
  • October 2014
  • 56 pages

A textual analysis of the financial results for Protalix Biotherapeutics Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Therapy | Countries: United States

Raptor Pharmaceutical Corp.

Raptor Pharmaceutical Corp.

  • $ 55
  • Company report
  • by Wright Investors' Service
  • October 2014
  • 55 pages

A textual analysis of the financial results for Raptor Pharmaceutical Corp. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Pharmaceutical | Countries: United States

Hayat Pharmaceutical Industries Co PSC

Hayat Pharmaceutical Industries Co PSC

  • $ 55
  • Company report
  • by Wright Investors' Service
  • October 2014
  • 56 pages

A textual analysis of the financial results for Hayat Pharmaceutical Industries Co PSC compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. ...

Industries: Pharmaceutical | Countries: United States

Cairo Pharmaceuticals & Chem. Industries

Cairo Pharmaceuticals & Chem. Industries

  • $ 55
  • Company report
  • by Wright Investors' Service
  • October 2014
  • 55 pages

A textual analysis of the financial results for Cairo Pharmaceuticals & Chem. Industries compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. ...

Industries: Pharmaceutical | Countries: United States

Malignant Melanoma: KOL Insight

Malignant Melanoma: KOL Insight

  • $ 6 495
  • Industry report
  • by Firstword Pharma
  • October 2014
  • 125 pages

Malignant Melanoma: PD-1 inhibitors revolutionise treatment is a comprehensive report with insights from 12 leading US and European KOLs offering their latest views on current and late-stage pipeline products, why and when they would prescribe them, and the factors likely to affect their future positioning ...

Industries: Pathology | Countries: United States

U.S. Physical Therapy, Inc.

U.S. Physical Therapy, Inc.

  • $ 55
  • Company report
  • by Wright Investors' Service
  • October 2014
  • 56 pages

A textual analysis of the financial results for U.S. Physical Therapy, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Therapy | Countries: United States

Adamis Pharmaceuticals Corporation (Symbol:ADMP) SWOT Analysis, Strategy, Revenues and Profits

Adamis Pharmaceuticals Corporation (Symbol:ADMP) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Adamis Pharmaceuticals Corporation SWOT Analysis report provides you ...

Industries: Pharmaceutical | Countries: United States

Aegerion Pharmaceuticals, Inc. (Symbol:AEGR) SWOT Analysis, Strategy, Revenues and Profits

Aegerion Pharmaceuticals, Inc. (Symbol:AEGR) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Aegerion Pharmaceuticals, Inc. SWOT Analysis report provides you a ...

Industries: Pharmaceutical | Countries: United States

Affymax, Inc. (Symbol:AFFY) SWOT Analysis, Strategy, Revenues and Profits

Affymax, Inc. (Symbol:AFFY) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Affymax, Inc. SWOT Analysis report provides you a strategic analysis ...

Industries: Pathology | Countries: United States

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 339 368 6001

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.